v3.26.1
Commitments and Contingencies (Additional Information) (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 02, 2026
Mar. 11, 2026
Aug. 20, 2025
Jun. 11, 2024
Nov. 30, 2025
Feb. 28, 2013
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Jan. 29, 2026
Aug. 31, 2025
Aug. 17, 2025
Commitments and Contingencies [Line Items]                        
Common Stock Share Price             $ 630          
Royalty expenses             $ 0 $ 100,000        
Prepayment costs   $ 100,000,000                    
Finance lease liabilities             $ 0          
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]             Derivative Liability, Noncurrent          
Lease Expense             $ 1,200,000 300,000        
Implementation fee related to sales             72,000          
Implementation fee of First Year             1,200,000          
Implementation fee of Second And Third Year             1,300,000          
Long Term Commitment Amount       $ 100,000,000                
Non-refundable deposit         $ 2,500,000              
Impairment Loss             0   $ 2,500,000      
Former Employee [Member]                        
Commitments and Contingencies [Line Items]                        
Agreement settlement payment             3,500,000          
Former Employee One[Member]                        
Commitments and Contingencies [Line Items]                        
Agreement settlement payment             $ 2,500,000          
Mr. Mack [Member] | Subsequent Event [Member]                        
Commitments and Contingencies [Line Items]                        
Payment for attorneys fees $ 5,300,000                      
Common Stock [Member]                        
Commitments and Contingencies [Line Items]                        
Common Stock Share Price     $ 16                  
Investor agreed to purchase Share     1,250,000                  
Aggregate purchase price     $ 20,000,000                  
Probudur [Member]                        
Commitments and Contingencies [Line Items]                        
Percentage on net sale             6.00%          
Envelta [Member]                        
Commitments and Contingencies [Line Items]                        
Percentage on net sale             6.00%          
Epoladerm [Member]                        
Commitments and Contingencies [Line Items]                        
Percentage on net sale             6.00%          
Product Development Agreement [Member] | Developers [Member]                        
Commitments and Contingencies [Line Items]                        
Royalty expenses             $ 900,000 700,000        
Accrued royalty payables             $ 1,800,000   2,100,000      
Agreement maturity date           Oct. 02, 2028            
Agreement maturity renewal description             The Product Development Agreement will renew automatically for subsequent successive one-year renewal periods unless Scilex Pharma or the Developers terminate it upon six-months’ written notice.          
Product Development Agreement [Member] | Developers [Member] | Minimum                        
Commitments and Contingencies [Line Items]                        
Royalty payment percentage related to future years             25.00%          
Product Development Agreement [Member] | Developers [Member] | Maximum                        
Commitments and Contingencies [Line Items]                        
Royalty payment percentage related to future years             35.00%          
Product Development Agreement [Member] | Scilex Pharma [Member]                        
Commitments and Contingencies [Line Items]                        
Royalty expenses             $ 1,200,000 $ 900,000        
Non-cancelable Lease Agreements [Member] | Minimum | Research and Development Facilities [Member]                        
Commitments and Contingencies [Line Items]                        
Operating lease, remaining lease term             1 year 6 months          
Operating lease, lease term             1 year          
Non-cancelable Lease Agreements [Member] | Maximum | Research and Development Facilities [Member]                        
Commitments and Contingencies [Line Items]                        
Operating lease, lease term             13 years          
Investment Agreement                        
Commitments and Contingencies [Line Items]                        
Contingent consideration, liability                 1,000,000   $ 2,500,000  
Investment Agreement | PA OPS Investor LLC [Member]                        
Commitments and Contingencies [Line Items]                        
Contingent consideration, liability             $ 2,500,000   2,500,000     $ 2,500,000
Long Term Commitment Amount             $ 2,500,000   $ 2,500,000      
Loan interest rate             4.03%   4.03%      
Common Stock Purchase Agreement [Member]                        
Commitments and Contingencies [Line Items]                        
Common Stock Share Price                   $ 0.14247    
Common Stock Share Purchases                   193,021,436    
Payments for Purchase of Common Stock                   $ 27,500,000